Skip to content

Ayurvedic Management of Amavata (Rheumatoid Arthritis) with Panchsam churna.

An Etiopathological study of Amavata w.s.r. to Rheumatoid Arthritis and its Upshayatamaka Parikshana with Panchsam Churna

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035324
Enrollment
60
Registered
2021-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 6- Extracorporeal or Systemic Therapies

Interventions

Intervention1: Panchsam churna: Drug name - Panchsam churna Refrence - Sharangdhar Action - Deepaniya, Shota har, Vedanashamak, Vivandha nasak Dose - 5 gram twice daily Anupaan - Luke warm water Route

Sponsors

Govt PG Ayurvedic college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patient having sign and symptoms of Amavata will considered for the present study. 2- Patient who had satisfied the criteria laid down by the American Rheumatism Association will selected and registered for detailed investigation and follow up .Patient has to satisfied atleast 4 of these 7 criteria. 3- Patients between 16 years to 60 years of age. 4- Both sex (of all the religion & caste).

Exclusion criteria

Exclusion criteria: 1- Complicated cases of Rheumatoid arthritis, associated with Diabetes mellitus and Hypertension. 2- Patients suffering from Carcinoma. 3- Patients suffering from Systemic diseases like- Chronic Renal disease, Heart disease etc. 4-Patient having HIV And other immune compromised diseases.

Design outcomes

Primary

MeasureTime frame
Upshayatmak Parikshan Of AmavataTimepoint: 30 Days

Secondary

MeasureTime frame
Upshayatmak Parikshan Of AmavataTimepoint: 7 Days

Countries

India

Contacts

Public ContactDr Avadhesh kumar

Govt. PG Ayurveda College and Hospital

Avadheshsaroj@gmail.com9455262663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026